التفاصيل البيبلوغرافية
| العنوان: |
Clinical subsets associated with different anti-aminoacyl transfer RNA synthetase antibodies and their association with coexisting anti-Ro52. |
| المؤلفون: |
Yoshioki Yamasaki, Minoru Satoh, Machiko Mizushima, Takahiro Okazaki, Hiroko Nagafuchi, Seido Ooka, Tomohiko Shibata, Hiromasa Nakano, Hitoshi Ogawa, Kohei Azuma, Akihiko Maeda, Kumiko Tonooka, Hiroshi Ito, Yukiko Takakuwa, Makoto Inoue, Hirofumi Mitomi, Tomofumi Kiyokawa, Kosei Tsuchida, Hiromi Matsushita, Hidenori Mikage |
| المصدر: |
Modern Rheumatology; 2016, Vol. 26 Issue 3, p403-409, 7p |
| مصطلحات موضوعية: |
AMINOACYL-tRNA synthetases, POLYMYOSITIS, IMMUNOPRECIPITATION, ENZYME-linked immunosorbent assay, LUNG diseases |
| مستخلص: |
Objective: To characterize clinical features of polymyositis/dermatomyositis (PM/DM) patients with different anti-aminoacyl transfer RNA synthetase (ARS) antibodies and their association with anti-Ro52. Methods: Autoantibodies in sera from 97 Japanese patients (36 PM, 56 DM, and 5 clinically amyopathic DM), who satisfied Bohan and Peter or modified Sontheimer's criteria, were characterized by immunoprecipitation and enzyme-linked immunosorbent assay. Clinical information was from medical records. Features associated with different anti-ARS and anti-Ro52 antibodies were analyzed. Results: The prevalence of anti-ARS was similar to other studies (Jo-1, 22%; EJ, 4%; OJ, 1%; PL-12, 1%), except for a high prevalence of anti-PL-7 (12%), which allowed us to characterize patients carrying this specificity. Serum creatine kinase43000 IU/l was less common in anti-PL-7-positive patients (57%) than anti-Jo-1-positive patients (18%) (p=0.0328) and was not found in anti-EJpositive individuals. Interstitial lung disease was common in anti-ARS-positive patients (97%) (p50.0001 vs. 48% in anti-ARS-negative). Anti-Ro52 antibodies were frequently detected with anti-ARS (59%) (57% in anti-Jo-1, 67% in anti-PL-7) (vs. 21% in anti-ARS-negative, p50.0002). Anti-Ro52 was associated with overlap syndrome (26%) (vs. 7% in anti-Ro52-negative, p=0.0119). Conclusions: Patients with different anti-ARS in combination with anti-Ro52 appear to be associated with distinctive clinical subsets. [ABSTRACT FROM AUTHOR] |
|
Copyright of Modern Rheumatology is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Find this article in full text from Springer Verlag. 
PDF full text from Publisher